The newborn and preterm infant population has varying degrees of fragile, underdeveloped skin that can be easily damaged by adhesives. Coupled with Casmed’s unique Cool-Light technology which eliminates
The company has reported a revenue of $1.04 billion for the first quarter of 2009, a 10% increase, compared to $942.19 million for the first quarter of 2008.
The company has reported net sales of $2.82 billion for the first quarter of 2009, a decrease of 2%, compared to $2.87 billion for the first quarter of
Funding for research using adult stem cells and induced pluripotent stem cells will continue. Funding will not be allowed for stem cells obtained from other sources, including somatic
Kowa Pharmaceuticals America, a specialty pharmaceutical company, has plans to divest its franchise of diclofenac products, including PRO-513 for the treatment of acute migraine headache pain and PRO-571
PPG Industries, a manufacturer of chemical products, reports a net loss of $111m in the first quarter, compared to a net loss of $100m for the same period
Industry, nonprofit and government experts shared their insights on a variety of topics, including the future of chemicals management and TSCA reform, coping with the latest Global Harmonization
Genomic Health, a life science company, has reported that the Quasar validation study met its primary endpoint to predict the likelihood of recurrence for stage II colon cancer
According to the agreed-upon terms, Nippon Kayaku will be responsible for regulatory strategy and seeking to obtain requisite product registrations, including performing any clinical studies that may be
Johnson & Johnson, LLC operates in Russia, Ukraine and CIS countries and is one of the subsidiaries of Johnson & Johnson. Johnson & Johnson LLC will have exclusive
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.